Online inquiry

IVTScrip™ mRNA-Human ANKRD20A4, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK21508MR)

This product GTTS-WK21508MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ANKRD20A4 protein. This product can be used in Mitotic arrest phase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 728747
UniProt ID Q4UJ75
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ANKRD20A4, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK21508MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK15525MR IVTScrip™ mRNA-Human ANKRD42, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA ANKRD42
GTTS-WK15808MR IVTScrip™ mRNA-Human ANKRD20A4, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ANKRD20A4
GTTS-WK8330MR IVTScrip™ mRNA-Human Additional GABA Compounds, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA Additional GABA Compounds
GTTS-WK26010MR IVTScrip™ mRNA-Human ASGR1, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ASGR1
GTTS-WK11935MR IVTScrip™ mRNA-Human ADGRD2, (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) mRNA ADGRD2
GTTS-WK26799MR IVTScrip™ mRNA-Human ARHGAP4, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARHGAP4
GTTS-WK20636MR IVTScrip™ mRNA-Human ANKRD7, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ANKRD7
GTTS-WK11197MR IVTScrip™ mRNA-Human AC133, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA AC133
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW